tiprankstipranks
Sino Biopharmaceutical Ltd (CH:SMZ1)
:SMZ1
Switzerland Market
SMZ1
Sino Biopharmaceutical
RESEARCH TOOLSreports

Sino Biopharmaceutical (SMZ1) Financial Statements

0 Followers

Sino Biopharmaceutical Financial Overview

Sino Biopharmaceutical's market cap is currently CHF9.74B. The company's EPS TTM is CHF0.133; its P/E ratio is 33.70; Sino Biopharmaceutical is scheduled to report earnings on August 19, 2026, and the estimated EPS forecast is CHF0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 31.83B¥ 28.87B¥ 26.20B¥ 26.03B¥ 26.86B
Gross Profit¥ 26.13B¥ 23.53B¥ 21.21B¥ 21.54B¥ 21.53B
Operating Income¥ 6.95B¥ 6.14B¥ 5.79B¥ 5.59B¥ 5.08B
EBITDA¥ 7.26B¥ 6.11B¥ 6.98B¥ 6.69B¥ 19.87B
Net Income¥ 2.34B¥ 3.50B¥ 2.33B¥ 2.54B¥ 14.61B
Balance Sheet
Cash & Short-Term Investments¥ 22.96B¥ 14.60B¥ 14.12B¥ 16.92B¥ 15.79B
Total Assets¥ 76.04B¥ 65.41B¥ 63.60B¥ 64.06B¥ 60.54B
Total Debt¥ 16.08B¥ 9.78B¥ 12.58B¥ 13.98B¥ 12.12B
Net Debt¥ 8.69B¥ 214.26M¥ 3.13B¥ 5.33B¥ 2.52B
Total Liabilities¥ 33.32B¥ 22.63B¥ 25.43B¥ 26.12B¥ 22.81B
Stockholders' Equity¥ 30.68B¥ 31.96B¥ 30.47B¥ 29.75B¥ 30.29B
Cash Flow
Free Cash Flow¥ 7.59B¥ 5.22B¥ 4.36B¥ 4.56B¥ 3.47B
Operating Cash Flow¥ 9.29B¥ 6.62B¥ 6.07B¥ 6.27B¥ 5.37B
Investing Cash Flow¥ -12.41B¥ -1.71B¥ -756.98M¥ -4.07B¥ -2.52B
Financing Cash Flow¥ 4.16B¥ -6.32B¥ -6.55B¥ -3.19B¥ -3.23B
Currency in CNY

Sino Biopharmaceutical Earnings and Revenue History

Income Statement >

Sino Biopharmaceutical Debt to Assets

Balance Sheet >

Sino Biopharmaceutical Cash Flow

Cash Flow >

Sino Biopharmaceutical Forecast EPS vs Actual EPS

Earnings >